- Home
- ATRA vs VTVT Comparison
ATRA vs VTVT Comparison
Compare ATRA & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- VTVT
- Stock Information
- Founded
- ATRA 2012
- VTVT 2015
- Country
- ATRA United States
- VTVT United States
- Employees
- ATRA N/A
- VTVT N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- ATRA Health Care
- VTVT Health Care
- Exchange
- ATRA Nasdaq
- VTVT Nasdaq
- Market Cap
- ATRA 51.1M
- VTVT 45.8M
- IPO Year
- ATRA 2014
- VTVT 2015
- Fundamental
- Price
- ATRA $11.58
- VTVT $15.54
- Analyst Decision
- ATRA Strong Buy
- VTVT Strong Buy
- Analyst Count
- ATRA 4
- VTVT 2
- Target Price
- ATRA $20.00
- VTVT $35.50
- AVG Volume (30 Days)
- ATRA 57.7K
- VTVT 5.7K
- Earning Date
- ATRA 08-11-2025
- VTVT 08-07-2025
- Dividend Yield
- ATRA N/A
- VTVT N/A
- EPS Growth
- ATRA N/A
- VTVT N/A
- EPS
- ATRA N/A
- VTVT N/A
- Revenue
- ATRA $199,732,000.00
- VTVT $17,000.00
- Revenue This Year
- ATRA N/A
- VTVT N/A
- Revenue Next Year
- ATRA N/A
- VTVT N/A
- P/E Ratio
- ATRA N/A
- VTVT N/A
- Revenue Growth
- ATRA 475.53
- VTVT N/A
- 52 Week Low
- ATRA $5.01
- VTVT $12.12
- 52 Week High
- ATRA $18.71
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- ATRA 66.87
- VTVT 42.29
- Support Level
- ATRA $8.53
- VTVT $16.57
- Resistance Level
- ATRA $13.46
- VTVT $17.46
- Average True Range (ATR)
- ATRA 0.96
- VTVT 0.70
- MACD
- ATRA 0.28
- VTVT 0.05
- Stochastic Oscillator
- ATRA 62.65
- VTVT 22.68
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.